Prediction of early course of breast carcinoma by thymidine labeling
暂无分享,去创建一个
[1] R. Silvestrini,et al. Cell proliferation and its relationship to clinical features and relapse in breast cancers , 1981 .
[2] M. Tubiana,et al. Kinetic parameters and the course of the disease in breast cancer , 1981, Cancer.
[3] J. Meyer,et al. Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival. , 1980, Cancer research.
[4] J. Meyer,et al. Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices. , 1979, Cancer research.
[5] M. Daidone,et al. Relationship between proliferative activity and estrogen receptors in breast cancer , 1979, Cancer.
[6] J. Meyer,et al. Estrogen receptor assay of carcinomas of the breast by a simplified dextran--charcoal method. , 1978, American journal of clinical pathology.
[7] Meyer Js,et al. Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content. , 1978 .
[8] J. Meyer,et al. In vitro labeling of solid tissues with tritiated thymidine for autoradiographic detection of S-phase nuclei. , 1977, Stain technology.
[9] C. Redmond,et al. L‐phenylalanine mustard (L‐PAM) in the management of primary breast cancer: An update of earlier findings and a comparison with those utilizing L‐PAM plus 5‐fluorouracil (5‐FU) , 1977, Cancer.
[10] G. Bonadonna,et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. , 1976, The New England journal of medicine.
[11] B. Fisher,et al. The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4) , 1975, Cancer.
[12] C. Redmond,et al. 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. , 1975, The New England journal of medicine.
[13] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .